CAMDEN NATIONAL CORP·4

Jun 3, 4:31 PM ET

Denekas Craig N 4

Research Summary

AI-generated summary

Updated

Camden National (CAC) Director Craig Denekas Receives 919-Share Award

What Happened Craig N. Denekas, a director of Camden National Corp (CAC), was granted/acquired 919 shares on 2026-06-01 as an award under the company’s equity program. The Form 4 reports the transaction as 919 shares at $0.00 (the filing shows $0.00 because the grant is an award — see footnote). The shares vested immediately on the grant date.

Key Details

  • Transaction date: 2026-06-01; Filing date: 2026-06-03 (appears to be filed within the standard two-business-day Form 4 window).
  • Reported price: $0.00 in the filing; footnote states price is N/A because these were director equity awards under the Independent Directors' Equity Compensation Program (part of the 2022 Equity and Incentive Plan and Amendment).
  • Shares awarded/received: 919; vested immediately on grant.
  • Shares owned after transaction: not specified in the summary information provided.
  • Transaction code: A (award/grant/acquisition).

Context Director awards like this are typically routine compensation for board service rather than an open-market purchase or sale. Because the award vested immediately and is disclosed as part of the company’s director compensation program, it should be viewed as compensation reporting rather than a direct market-confidence signal.